{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T19:38:19Z","timestamp":1767382699026,"version":"3.44.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.contraception.2020.01.010","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T19:36:47Z","timestamp":1580499407000},"page":"333-337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Perceptions of long-acting reversible contraception among women receiving medication for opioid use disorder in Vermont"],"prefix":"10.1016","volume":"101","author":[{"given":"Catalina N.","family":"Rey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary J.","family":"Badger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi S.","family":"Melbostad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah","family":"Wachtel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacey C.","family":"Sigmon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren K.","family":"MacAfee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne K.","family":"Dougherty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah H.","family":"Heil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2020.01.010_b0005","doi-asserted-by":"crossref","first-page":"845","DOI":"10.15585\/mmwr.mm6731a1","article-title":"Opioid use disorder documented at delivery hospitalization\u2014United States, 1999\u20132014","volume":"67","author":"Haight","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.contraception.2020.01.010_b0010","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/jp.2015.36","article-title":"Increasing incidence and geographic distribution of neonatal abstinence syndrome: Unites States 2009 to 2012","volume":"35","author":"Patrick","year":"2015","journal-title":"J Perinatol"},{"key":"10.1016\/j.contraception.2020.01.010_b0015","doi-asserted-by":"crossref","first-page":"242","DOI":"10.15585\/mmwr.mm6609a2","article-title":"CDC grand rounds: public health strategies to prevent neonatal abstinence syndrome","volume":"66","author":"Ko","year":"2017","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"issue":"3","key":"10.1016\/j.contraception.2020.01.010_b0020","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-4070","article-title":"A public health response to opioid use in pregnancy","volume":"139","author":"Patrick","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.contraception.2020.01.010_b0025","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jsat.2010.08.011","article-title":"Unintended pregnancy in opioid-abusing women","volume":"40","author":"Heil","year":"2011","journal-title":"J Subst Abus Treat"},{"key":"10.1016\/j.contraception.2020.01.010_b0030","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.contraception.2011.01.021","article-title":"Contraceptive failure in the United States","volume":"83","author":"Trussell","year":"2011","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.contraception.2020.01.010_b0035","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.contraception.2018.04.012","article-title":"Continuation of long-acting reversible contraceptives among medicaid patients","volume":"98","author":"Romano","year":"2018","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2020.01.010_b0040","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2165\/11591290-000000000-00000","article-title":"Efficacy and safety of long-acting reversible contraception","volume":"71","author":"Stoddard","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.contraception.2020.01.010_b0045","first-page":"1","article-title":"Two year continuation rates of contraceptive methods in France: a cohort study from the French national health insurance database","author":"Agostini","year":"2018","journal-title":"Eur J Contraception Reprod Health Care"},{"key":"10.1016\/j.contraception.2020.01.010_b0050","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.contraception.2018.02.001","article-title":"Not seeking yet trying long-acting reversible contraception: a 24-month randomized trial on continuation, unintended pregnancy and satisfaction","volume":"97","author":"Hubacher","year":"2018","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2020.01.010_b0055","first-page":"1","article-title":"Current contraceptive status among women aged 15\u201344: United States, 2011\u20132013","volume":"173","author":"Daniels","year":"2014","journal-title":"NCHS Data Brief"},{"key":"10.1016\/j.contraception.2020.01.010_b0060","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1089\/jwh.2017.6564","article-title":"Reproductive health knowledge, attitudes, and behaviors among women enrolled in medication-assisted treatment for opioid use disorder","volume":"10","author":"Meschke","year":"2018","journal-title":"J Women\u2019s Health"},{"key":"10.1016\/j.contraception.2020.01.010_b0065","first-page":"1","article-title":"Contraceptive choices for reproductive age women at methadone clinics in Western North Carolina","volume":"2","author":"Poulton","year":"2015","journal-title":"MaAHEC Online J Res"},{"key":"10.1016\/j.contraception.2020.01.010_b0070","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.contraception.2017.07.167","article-title":"Knowledge of and concerns about long-acting reversible contraception among women in medication-assisted treatment for opioid use disorder","volume":"96","author":"Matusiewicz","year":"2017","journal-title":"Contraception"},{"issue":"2","key":"10.1016\/j.contraception.2020.01.010_b0075","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap) \u2013 a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.contraception.2020.01.010_b0080","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.contraception.2016.02.007","article-title":"\u201cI don\u2019t know enough to feel comfortable using them:\u201d women\u2019s knowledge of and perceived barriers to long-acting reversible contraceptives on a college campus","volume":"93","author":"Hall","year":"2016","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.contraception.2020.01.010_b0085","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.stamet.2011.01.002","article-title":"Tests of homogeneity for partially matched-pairs data","volume":"8","author":"Samawi","year":"2011","journal-title":"Stat Methodol"},{"issue":"5","key":"10.1016\/j.contraception.2020.01.010_b0090","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1111\/j.1420-9101.2005.00917.x","article-title":"Combining probability from independent tests: the weighted z-method is superior to Fisher's approach","volume":"18","author":"Whitlock","year":"2005","journal-title":"J Evol Biol"},{"key":"10.1016\/j.contraception.2020.01.010_b0095","unstructured":"Toolkits. Managing Side Effects for IUDs. Available at: https:\/\/toolkits.knowledgesuccess.org\/toolkits\/iud\/managing-side-effects-iuds. Accessed on 11\/22\/2019."},{"issue":"1","key":"10.1016\/j.contraception.2020.01.010_b0100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/biores.2017.0037","article-title":"Patient-perceived autonomy and long-acting reversible contraceptive use: a qualitative assessment in a Midwestern, university community","volume":"7","author":"Zeal","year":"2018","journal-title":"BioRes Open Access"},{"issue":"6","key":"10.1016\/j.contraception.2020.01.010_b0105","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2307\/2135777","article-title":"Barriers to family planning among patients in drug treatment programs","volume":"23","author":"Armstrong","year":"1991","journal-title":"Family Plan Perspect"},{"issue":"2","key":"10.1016\/j.contraception.2020.01.010_b0110","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2524.2007.00739.x","article-title":"Barriers to accessing generic health and social care services: a qualitative study of injecting drug users","volume":"16","author":"Neale","year":"2008","journal-title":"Health Social Care Community"},{"issue":"7","key":"10.1016\/j.contraception.2020.01.010_b0115","first-page":"92","article-title":"Stigmatization by nurses as perceived by substance abuse patients: a phenomenological study","volume":"3","author":"Sleeper","year":"2013","journal-title":"J Nurs Educ Pract"},{"key":"10.1016\/j.contraception.2020.01.010_b0120","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1007\/s00127-013-0704-0","article-title":"Public opinion on imposing restrictions to people with an alcohol- or drug addiction: a cross-sectional survey","volume":"48","author":"van Boekel","year":"2013","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"3","key":"10.1016\/j.contraception.2020.01.010_b0125","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.drugalcdep.2004.08.017","article-title":"Co-morbid post-traumatic stress disorder in a substance misusing clinical population","volume":"77","author":"Reynolds","year":"2005","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.contraception.2020.01.010_b0130","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1530-0277.2007.00591.x","article-title":"Trauma and PTSD in patients with alcohol, drug, or dual dependence: a multi-center study","volume":"32","author":"Driessen","year":"2008","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.contraception.2020.01.010_b0135","unstructured":"Substance Abuse and Mental Health Services Administration. SAMHSA\u2019s Concept of Trauma and Guidance for a Trauma-Informed Approach. HHS Publication No. (SMA) 14-4884. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2014."},{"key":"10.1016\/j.contraception.2020.01.010_b0140","doi-asserted-by":"crossref","unstructured":"American College of Obstetricians and Gynecologists. Sexual assault. ACOG Committee Opinion No. 777. Obstet Gynecol 2019;133:e296\u2013302.","DOI":"10.1097\/AOG.0000000000003178"},{"key":"10.1016\/j.contraception.2020.01.010_b0145","unstructured":"Substance Abuse and Mental Health Services Administration. Clinical Guidance for Treating Pregnant and Parenting Women with Opioid Use Disorder and Their Infants. Available at: https:\/\/store.samhsa.gov\/system\/files\/sma18-5054.pdf. Accessed on 11\/22\/2019."},{"issue":"1","key":"10.1016\/j.contraception.2020.01.010_b0150","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.contraception.2014.01.025","article-title":"Interest in and experience with IUD self-removal","volume":"90","author":"Foster","year":"2014","journal-title":"Contraception"},{"issue":"1","key":"10.1016\/j.contraception.2020.01.010_b0155","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/pm\/pny025","article-title":"Buprenorphine maintenance subjects are hyperalgesic and have no antinociceptive response to a very high morphine dose","volume":"20","author":"Athanasos","year":"2019","journal-title":"Pain Med"},{"key":"10.1016\/j.contraception.2020.01.010_b0160","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.pain.2005.11.005","article-title":"Methadone maintenance patients are cross tolerant to the antinociceptive effects of very high plasma morphine concentrations","volume":"120","author":"Athanasos","year":"2006","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.contraception.2020.01.010_b0165","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jpain.2012.01.001","article-title":"Hyperalgesia in heroin dependent patients and the effects of opioid substitution therapy","volume":"13","author":"Compton","year":"2012","journal-title":"J Pain"},{"key":"10.1016\/j.contraception.2020.01.010_b0170","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.contraception.2019.01.002","article-title":"Shared negative experiences of long-acting reversible contraception and their influence on contraceptive decision-making: a multi-methods study","volume":"99","author":"Brown","year":"2019","journal-title":"Contraception"},{"issue":"3","key":"10.1016\/j.contraception.2020.01.010_b0175","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1363\/46e1814","article-title":"Women\u2019s social communication about IUDs: a qualitative analysis","volume":"46","author":"Anderson","year":"2014","journal-title":"Perspect Sex Reprod Health"},{"issue":"2","key":"10.1016\/j.contraception.2020.01.010_b0180","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.1097\/JPN.0000000000000401","article-title":"Barriers to reproductive healthcare for women with opioid use disorder","volume":"33","author":"Smith","year":"2019","journal-title":"J Perinat Neonat Nurs"},{"key":"10.1016\/j.contraception.2020.01.010_b0185","first-page":"1","article-title":"Trends in long-acting reversible contraception use among U.S. women aged 15\u201344","volume":"188","author":"Branum","year":"2015","journal-title":"NCHS Data Brief"},{"issue":"5","key":"10.1016\/j.contraception.2020.01.010_b0190","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.contraception.2015.12.010","article-title":"Racial and ethnic differences in women\u2019s preferences for features of contraceptive methods","volume":"93","author":"Jackson","year":"2016","journal-title":"Contraception"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782420300299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782420300299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T20:15:42Z","timestamp":1757880942000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782420300299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0010782420300299"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2020.01.010","relation":{},"ISSN":["0010-7824"],"issn-type":[{"type":"print","value":"0010-7824"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perceptions of long-acting reversible contraception among women receiving medication for opioid use disorder in Vermont","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2020.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}